<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
     xmlns:admin="http://webns.net/mvcb/"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Bersama Kita Sehat &#45; : Infection &amp;amp; Diagnostic</title>
<link>https://edusehat.com/en/rss/category/infection</link>
<description>Bersama Kita Sehat &#45; : Infection &amp;amp; Diagnostic</description>
<dc:language>en</dc:language>
<dc:rights>2025&#45;2055 PS Global Media &#45; Hak Cipta</dc:rights>

<item>
<title>Acutis Expands Diagnostic Services into Kentucky, Strengthening Payer Collaboration Through Value&#45;Driven Care</title>
<link>https://edusehat.com/en/acutis-expands-diagnostic-services-into-kentucky-strengthening-payer-collaboration-through-value-driven-care</link>
<guid>https://edusehat.com/en/acutis-expands-diagnostic-services-into-kentucky-strengthening-payer-collaboration-through-value-driven-care</guid>
<description><![CDATA[  
    
 
 
  
   
    
     
     Kentucky, USA - 26 March 2026 — New York-based Acutis Diagnostics, a leader in advanced clinical testing and actionable diagnostic insights, today announced the expansion of its services into the state of Kentucky as a contracted provider with Humana. 
     This expansion of our payor network reflects Acutis’ continued commitment to improving access to reliable diagnostic services while aligning closely with healthcare providers and payer organizations to support better patient outcomes. 
     This relationship represents Acutis’ broader partnership approach with payers, focused on delivering measurable value, improving clinical visibility, and supporting informed decision-making across care programs. 
     “We believe the relationship between patient, provider, and payor should create value for every stakeholder,” said Jibreel Sarij, CEO. “When we challenge outdated assumptions and move beyond a zero-sum mindset, it becomes clear that a healthier patient is the most meaningful and universally beneficial outcome for all stakeholders.” 
     Acutis is actively working with payer partners and healthcare stakeholders to demonstrate the real-world impact its diagnostics deliver.  
       
      
     About Acutis DiagnosticsAcutis Diagnostics provides advanced clinical testing solutions designed to deliver actionable insights for healthcare providers. With a focus on accuracy, speed, and clinical relevance, Acutis helps turn laboratory data into meaningful information that supports better patient care and program outcomes. For more information, visit https://www.acutis.com/diagnostics 
     
    
   
  
 ]]></description>
<enclosure url="https://blog.acutis.com/hubfs/blog-kentucky%20copy-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Thu, 26 Mar 2026 23:30:03 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Acutis, Expands, Diagnostic, Services, into, Kentucky, Strengthening, Payer, Collaboration, Through, Value-Driven, Care</media:keywords>
<content:encoded><![CDATA[<div class="hs-featured-image-wrapper"> 
 <a href="https://blog.acutis.com/post/press-release-acutis-expands-diagnostic-services-into-kentucky" title="" class="hs-featured-image-link"> <img src="https://blog.acutis.com/hubfs/blog-kentucky%20copy-1.jpg" alt="Acutis Expands Diagnostic Services into Kentucky, Strengthening Payer Collaboration Through Value-Driven Care" class="hs-featured-image"> </a> 
</div> 
<div class="NjQ71C"> 
 <div class="NjQ71C"> 
  <div class="kvdbP HWlYoF wrLZsV _1O7aH"> 
   <div class="_1hN1O uyQefQ"> 
    <div class="_2vd5k b6lcWf"> 
     <p><strong><span>Kentucky, USA - 26 March 2026</span></strong><span> — New York-based Acutis Diagnostics, a leader in advanced clinical testing and actionable diagnostic insights, today announced the expansion of its services into the state of Kentucky as a contracted provider with Humana.</span></p> 
     <p><span>This expansion of our payor network reflects Acutis’ continued commitment to improving access to reliable diagnostic services while aligning closely with healthcare providers and payer organizations to support better patient outcomes.</span></p> 
     <p><span>This relationship represents Acutis’ broader partnership approach with payers, focused on delivering measurable value, improving clinical visibility, and supporting informed decision-making across care programs.</span></p> 
     <p><span>“<em><span>We believe the relationship between patient, provider, and payor should create value for every stakeholder,</span>”</em> said Jibreel Sarij, CEO. “<span><em>When we challenge outdated assumptions and move beyond a zero-sum mindset, it becomes clear that a healthier patient is the most meaningful and universally beneficial outcome for all stakeholders.</em></span>”</span></p> 
     <p><span>Acutis is actively working with payer partners and healthcare stakeholders to demonstrate the real-world impact its diagnostics deliver. </span></p> 
     <div>  
     </div> 
     <p><strong><span>About Acutis Diagnostics</span></strong><span><br>Acutis Diagnostics provides advanced clinical testing solutions designed to deliver actionable insights for healthcare providers. With a focus on accuracy, speed, and clinical relevance, Acutis helps turn laboratory data into meaningful information that supports better patient care and program outcomes. <br><br>For more information, visit </span><a href="https://www.acutis.com/diagnostics"><span>https://www.acutis.com/diagnostics</span></a></p> 
    </div> 
   </div> 
  </div> 
 </div> 
</div>  
<img src="https://track.hubspot.com/__ptq.gif?a=21140295&k=14&r=https%3A%2F%2Fblog.acutis.com%2Fpost%2Fpress-release-acutis-expands-diagnostic-services-into-kentucky&bu=https%253A%252F%252Fblog.acutis.com&bvt=rss" alt="" width="1" height="1">]]> </content:encoded>
</item>

<item>
<title>How having access to an extensive fentanyl testing Menu saves lives</title>
<link>https://edusehat.com/en/how-having-access-to-an-extensive-fentanyl-testing-menu-saves-lives</link>
<guid>https://edusehat.com/en/how-having-access-to-an-extensive-fentanyl-testing-menu-saves-lives</guid>
<description><![CDATA[  
    
 
How Fentanyl Testing Saves Lives 
According to the CDC, Fentanyl is a major contributor to fatal and nonfatal overdoses in the U.S. The dangers of fentanyl are realized across the country with over 150 people dying every day from overdoses related to synthetic opioids like fentanyl. Fentanyl is a powerful synthetic opioid that has been linked to a rising number of overdose deaths in recent years. It is 50x stronger than heroin and 100x stronger than morphine. It is highly potent and can be deadly in small amounts, which is why it is essential to have an extensive fentanyl testing menu to ensure that any product or substance that may contain fentanyl can be accurately identified.It is also important to call attention to the difference between Pharmaceutical fentanyl and illicitly manufactured fentanyl, with the latter being uncontrolled making it difficult to determine appropriate dosage to avoid unintentional overdose and other harms. The reason is that illicitly-manufactured fentanyl is unregulated, and of unknown composition and potency making it difficult to determine appropriate dosage to avoid unintentional overdose and other harms. ]]></description>
<enclosure url="https://blog.acutis.com/hubfs/image001%20(23).jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 23 Feb 2026 13:08:46 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>How, having, access, extensive, fentanyl, testing, Menu, saves, lives</media:keywords>
<content:encoded><![CDATA[<div class="hs-featured-image-wrapper"> 
 <a href="https://blog.acutis.com/how-having-access-to-an-extensive-fentanyl-testing-panel-saves-lives" title="" class="hs-featured-image-link"> <img src="https://blog.acutis.com/hubfs/image001%20(23).jpg" alt="toxicology testing lab, fentanyl drug testing, drug testing lab ny " class="hs-featured-image"> </a> 
</div> 
<h2><span>How Fentanyl Testing Saves Lives</span></h2> 
<p>According to the CDC, Fentanyl is a major contributor to fatal and nonfatal overdoses in the U.S. <br>The dangers of fentanyl are realized across the country with over 150 people dying every day from overdoses related to synthetic opioids like fentanyl. Fentanyl is a powerful synthetic opioid that has been linked to a rising number of overdose deaths in recent years. It is 50x stronger than heroin and 100x stronger than morphine. It is highly potent and can be deadly in small amounts, which is why it is essential to have an extensive fentanyl testing menu to ensure that any product or substance that may contain fentanyl can be accurately identified.<br><br>It is also important to call attention to the difference between Pharmaceutical fentanyl and illicitly manufactured fentanyl, with the latter being uncontrolled making it difficult to determine appropriate dosage to avoid unintentional overdose and other harms. The reason is that illicitly-manufactured fentanyl is unregulated, and of unknown composition and potency making it difficult to determine appropriate dosage to avoid unintentional overdose and other harms.</p>  
<img src="https://track.hubspot.com/__ptq.gif?a=21140295&k=14&r=https%3A%2F%2Fblog.acutis.com%2Fhow-having-access-to-an-extensive-fentanyl-testing-panel-saves-lives&bu=https%253A%252F%252Fblog.acutis.com&bvt=rss" alt="" width="1" height="1">]]> </content:encoded>
</item>

<item>
<title>The Top Infectious Diseases we see in the Spring &amp;amp; How to Stay Healthy</title>
<link>https://edusehat.com/en/the-top-infectious-diseases-we-see-in-the-spring-how-to-stay-healthy</link>
<guid>https://edusehat.com/en/the-top-infectious-diseases-we-see-in-the-spring-how-to-stay-healthy</guid>
<description><![CDATA[  
    
 
As we enter the spring of 2023, it&#039;s important to be aware of the top infectious diseases that we may encounter and take steps to stay healthy.  
  ]]></description>
<enclosure url="https://blog.acutis.com/hubfs/blog-top%20infectious%20diseases%20we%20see%20in%20the%20spring%20copy.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 23 Feb 2026 13:08:46 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>The, Top, Infectious, Diseases, see, the, Spring, How, Stay, Healthy</media:keywords>
<content:encoded><![CDATA[<div class="hs-featured-image-wrapper"> 
 <a href="https://blog.acutis.com/the-top-infectious-diseases-we-see-in-the-spring-and-how-to-stay-healthy" title="" class="hs-featured-image-link"> <img src="https://blog.acutis.com/hubfs/blog-top%20infectious%20diseases%20we%20see%20in%20the%20spring%20copy.jpg" alt="infectious disease testing lab, drug testing lab ny" class="hs-featured-image"> </a> 
</div> 
<h2><span><span>As we enter the spring of 2023, it's important to be aware of the top infectious diseases that we may encounter and take steps to stay healthy. </span></span></h2> 
<h6> </h6>  
<img src="https://track.hubspot.com/__ptq.gif?a=21140295&k=14&r=https%3A%2F%2Fblog.acutis.com%2Fthe-top-infectious-diseases-we-see-in-the-spring-and-how-to-stay-healthy&bu=https%253A%252F%252Fblog.acutis.com&bvt=rss" alt="" width="1" height="1">]]> </content:encoded>
</item>

<item>
<title>Understanding the Impact of the Pandemic on the US Drug Epidemic</title>
<link>https://edusehat.com/en/understanding-the-impact-of-the-pandemic-on-the-us-drug-epidemic</link>
<guid>https://edusehat.com/en/understanding-the-impact-of-the-pandemic-on-the-us-drug-epidemic</guid>
<description><![CDATA[  
    
 
Understanding the Pandemic’s Influence on the US Drug Epidemic from a Clinician’s Perspective  
  
When the COVID-19 Pandemic started in early 2020, the nation was nearly a decade into battling a rapidly growing Prescription Opioids Misuse Epidemic. Just three years prior, the crisis had been named a public health emergency, but that had done little to slow down the increase of opioid misuse and overdose deaths.  ]]></description>
<enclosure url="https://blog.acutis.com/hubfs/top-Blog-UNDERSTANDING%20THE%20IMPACT%20OF%20THE%20PANDEMIC%20ON%20THE%20US%20DRUG%20EPIDEMIC%20copy-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 23 Feb 2026 13:08:46 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Understanding, the, Impact, the, Pandemic, the, Drug, Epidemic</media:keywords>
<content:encoded><![CDATA[<div class="hs-featured-image-wrapper"> 
 <a href="https://blog.acutis.com/understanding-the-impact-of-the-pandemic-on-the-us-drug-epidemic" title="" class="hs-featured-image-link"> <img src="https://blog.acutis.com/hubfs/top-Blog-UNDERSTANDING%20THE%20IMPACT%20OF%20THE%20PANDEMIC%20ON%20THE%20US%20DRUG%20EPIDEMIC%20copy-1.jpg" alt="fentanyl testing lab ny, clinical toxicology testing lab ny nj " class="hs-featured-image"> </a> 
</div> 
<h2><span>Understanding the Pandemic’s Influence on the US Drug Epidemic from a Clinician’s Perspective </span></h2> 
<h5> </h5> 
<h6><span>When the COVID-19 Pandemic started in early 2020, the nation was nearly a decade into battling a rapidly growing Prescription Opioids Misuse Epidemic. Just three years prior, the crisis had been named a public health emergency, but that had done little to slow down the increase of opioid misuse and overdose deaths. </span></h6>  
<img src="https://track.hubspot.com/__ptq.gif?a=21140295&k=14&r=https%3A%2F%2Fblog.acutis.com%2Funderstanding-the-impact-of-the-pandemic-on-the-us-drug-epidemic&bu=https%253A%252F%252Fblog.acutis.com&bvt=rss" alt="" width="1" height="1">]]> </content:encoded>
</item>

<item>
<title>Animal microbiomes hold the key to new antifungals</title>
<link>https://edusehat.com/en/animal-microbiomes-hold-the-key-to-new-antifungals</link>
<guid>https://edusehat.com/en/animal-microbiomes-hold-the-key-to-new-antifungals</guid>
<description><![CDATA[  
    
 
With an increasing number of immunocompromised people with underlying diseases and treatments for other diseases like transplantation and cancer, fungal infections (mycosis), and diseases caused by fungus (yeast or mold) are increasing.  ]]></description>
<enclosure url="https://blog.acutis.com/hubfs/animal%20blog%20march%202023%20still%20pic.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 23 Feb 2026 13:08:46 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Animal, microbiomes, hold, the, key, new, antifungals</media:keywords>
<content:encoded><![CDATA[<div class="hs-featured-image-wrapper"> 
 <a href="https://blog.acutis.com/animal-microbiomes-hold-the-key-to-new-antifungals" title="" class="hs-featured-image-link"> <img src="https://blog.acutis.com/hubfs/animal%20blog%20march%202023%20still%20pic.jpg" alt="infectious disease research testing lab pcr tests ny nj " class="hs-featured-image"> </a> 
</div> 
<p><span>With an increasing number of immunocompromised people with underlying diseases and treatments for other diseases like transplantation and cancer, fungal infections (mycosis), and diseases caused by fungus (yeast or mold) are increasing. </span></p>  
<img src="https://track.hubspot.com/__ptq.gif?a=21140295&k=14&r=https%3A%2F%2Fblog.acutis.com%2Fanimal-microbiomes-hold-the-key-to-new-antifungals&bu=https%253A%252F%252Fblog.acutis.com&bvt=rss" alt="" width="1" height="1">]]> </content:encoded>
</item>

<item>
<title>FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine | FDA</title>
<link>https://edusehat.com/en/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine-fda</link>
<guid>https://edusehat.com/en/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine-fda</guid>
<description><![CDATA[  
    
 
 Respiratory Syncytial Virus (RSV) is a common respiratory virus that usually causes mild, cold-like symptoms, but can be serious for infants and older adults, resulting in an average of 60,000-160,000 hospitalizations and around 600-10,000 deaths per year in the US, with the highest death in people over 65. There is great news that on May 3, 2023, FDA approved the world’s first RSV vaccine for use in people aged 60 and older. ]]></description>
<enclosure url="https://blog.acutis.com/hubfs/blog-FDA%20approves%20first%20Respiratory%20Syncytial%20Virus%20(RSV)%20Vaccine%20copy%202.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 23 Feb 2026 13:08:45 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>FDA, Approves, First, Respiratory, Syncytial, Virus, RSV, Vaccine, FDA</media:keywords>
<content:encoded><![CDATA[<div class="hs-featured-image-wrapper"> 
 <a href="https://blog.acutis.com/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine-fda" title="" class="hs-featured-image-link"> <img src="https://blog.acutis.com/hubfs/blog-FDA%20approves%20first%20Respiratory%20Syncytial%20Virus%20(RSV)%20Vaccine%20copy%202.jpg" alt="FDA approved the world’s first RSV vaccine for use in people aged 60 and older, infectious disease, testing lab, diagnostics" class="hs-featured-image"> </a> 
</div> 
<p><span> Respiratory Syncytial Virus (RSV) is a common respiratory virus that usually causes mild, cold-like symptoms, but can be serious for infants and older adults, resulting in an average of 60,000-160,000 hospitalizations and around 600-10,000 deaths per year in the US, with the highest death in people over 65. There is great news that on May 3, 2023, FDA approved the world’s first RSV vaccine for use in people aged 60 and older.</span></p>  
<img src="https://track.hubspot.com/__ptq.gif?a=21140295&k=14&r=https%3A%2F%2Fblog.acutis.com%2Ffda-approves-first-respiratory-syncytial-virus-rsv-vaccine-fda&bu=https%253A%252F%252Fblog.acutis.com&bvt=rss" alt="" width="1" height="1">]]> </content:encoded>
</item>

<item>
<title>Drug&#45;resistant gonorrhea is no match for a new class of antibiotics</title>
<link>https://edusehat.com/en/drug-resistant-gonorrhea-is-no-match-for-a-new-class-of-antibiotics</link>
<guid>https://edusehat.com/en/drug-resistant-gonorrhea-is-no-match-for-a-new-class-of-antibiotics</guid>
<description><![CDATA[  
    
 
Sexually Transmitted Infections affect more than one million new people every day. 
Sexually Transmitted Infection (STI) is an infection of the genitourinary system transmitted through unprotected sexual contact infecting more than 1 million new people every day worldwide. While more than 30 different bacteria, viruses, and parasites are known to cause STIs, eight pathogens, including the causative agent of gonorrhea, Neisseria gonorrhoeae bacterium, are linked to the greatest incidence of STIs. The progressive development of drug resistance to many commonly used antibiotics to treat gonorrhea is highly concerning. ]]></description>
<enclosure url="https://blog.acutis.com/hubfs/blog-Drug-resistant%20gonorrhea%20is%20no%20match%20for%20a%20new%20class%20of%20antibiotics%20copy%202-1.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 23 Feb 2026 13:08:45 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Drug-resistant, gonorrhea, match, for, new, class, antibiotics</media:keywords>
<content:encoded><![CDATA[<div class="hs-featured-image-wrapper"> 
 <a href="https://blog.acutis.com/drug-resistant-gonorrhea-is-no-match-for-a-new-class-of-antibiotics" title="" class="hs-featured-image-link"> <img src="https://blog.acutis.com/hubfs/blog-Drug-resistant%20gonorrhea%20is%20no%20match%20for%20a%20new%20class%20of%20antibiotics%20copy%202-1.jpg" alt="infectious disease test, testing lab, UTI testing, infectious disease testing, AMR, Urinary Tract Infection Testing" class="hs-featured-image"> </a> 
</div> 
<h2><span><span>Sexually Transmitted Infections affect more than one million new people every day.</span></span></h2> 
<p><span>Sexually Transmitted Infection (STI) is an infection of the genitourinary system transmitted through unprotected sexual contact infecting more than 1 million new people every day worldwide. While more than 30 different bacteria, viruses, and parasites are known to cause STIs, eight pathogens, including the causative agent of gonorrhea, Neisseria gonorrhoeae bacterium, are linked to the greatest incidence of STIs. The progressive development of drug resistance to many commonly used antibiotics to treat gonorrhea is highly concerning.</span></p>  
<img src="https://track.hubspot.com/__ptq.gif?a=21140295&k=14&r=https%3A%2F%2Fblog.acutis.com%2Fdrug-resistant-gonorrhea-is-no-match-for-a-new-class-of-antibiotics&bu=https%253A%252F%252Fblog.acutis.com&bvt=rss" alt="" width="1" height="1">]]> </content:encoded>
</item>

<item>
<title>&#45; Science Direct</title>
<link>https://edusehat.com/en/science-direct</link>
<guid>https://edusehat.com/en/science-direct</guid>
<description><![CDATA[  
    
 
Urinary tract infection (UTI) is one of the most common bacterial infections infecting any part of the urinary system from the urethra, bladder, and ureter, to the kidney. It affects more than 150 million people worldwide both in the community and hospital setting. In most of the complicated and chronic UTIs, biofilm - a community of bacterial cells sticking together, and attaching to the bladder wall, is involved. Unfortunately, many antimicrobial-resistant UTI pathogens like Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa, Acinetobacter baumannii, etc. form biofilms. 
  ]]></description>
<enclosure url="https://blog.acutis.com/hubfs/blog-A%20Pseudomonas%20aeruginos-2%20copy.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 23 Feb 2026 13:08:44 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Science, Direct</media:keywords>
<content:encoded><![CDATA[<div class="hs-featured-image-wrapper"> 
 <a href="https://blog.acutis.com/a-pseudomonas-aeruginosa-pqs-quorum-sensing-system-inhibitor-with-anti-staphylococcal-activity-sensitizes-polymicrobial-biofilms-to-tobramycin-sciencedirect-1" title="" class="hs-featured-image-link"> <img src="https://blog.acutis.com/hubfs/blog-A%20Pseudomonas%20aeruginos-2%20copy.jpg" alt="infectious disease, testing lab, diagnostics, Urinary tract infection, UTI, PCR testing for UTIs is the new standard for identification" class="hs-featured-image"> </a> 
</div> 
<p>Urinary tract infection (UTI) is one of the most common bacterial infections infecting any part of the urinary system from the urethra, bladder, and ureter, to the kidney. It affects more than 150 million people worldwide both in the community and hospital setting. In most of the complicated and chronic UTIs, biofilm - a community of bacterial cells sticking together, and attaching to the bladder wall, is involved. Unfortunately, many antimicrobial-resistant UTI pathogens like Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa, Acinetobacter baumannii, etc. form biofilms.</p> 
<p> </p>  
<img src="https://track.hubspot.com/__ptq.gif?a=21140295&k=14&r=https%3A%2F%2Fblog.acutis.com%2Fa-pseudomonas-aeruginosa-pqs-quorum-sensing-system-inhibitor-with-anti-staphylococcal-activity-sensitizes-polymicrobial-biofilms-to-tobramycin-sciencedirect-1&bu=https%253A%252F%252Fblog.acutis.com&bvt=rss" alt="" width="1" height="1">]]> </content:encoded>
</item>

<item>
<title>Mail&#45;backs for Opioid Analgesics Dispensed in Outpatient Settings |FDA</title>
<link>https://edusehat.com/en/mail-backs-for-opioid-analgesics-dispensed-in-outpatient-settings-fda</link>
<guid>https://edusehat.com/en/mail-backs-for-opioid-analgesics-dispensed-in-outpatient-settings-fda</guid>
<description><![CDATA[  
    
 
Opioid Use Disorder (OUD)  
is one of the biggest public health threats of this era with nearly 50,000 deaths (mostly preventable) from Opioid overdoses only in the US in 2019. Recently, there is an increasing trend of prescription opioid use for the treatment of chronic, non-cancer pain, such as back pain or osteoarthritis, despite serious risks and the lack of evidence for effectiveness. Unfortunately, there were nearly five times higher overdose deaths involving prescription opioids in 2020 than in 1999. In 2020 alone, almost 24% of all US opioid overdose deaths involved a prescription opioid. Since 1999, more than 263,000 people have died in the US from prescription opioid overdoses. These trends warranted immediate actions from government agencies. 
  ]]></description>
<enclosure url="https://blog.acutis.com/hubfs/BLOG-FDA-MAY25%20copy.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 23 Feb 2026 13:08:43 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Mail-backs, for, Opioid, Analgesics, Dispensed, Outpatient, Settings, FDA</media:keywords>
<content:encoded><![CDATA[<div class="hs-featured-image-wrapper"> 
 <a href="https://blog.acutis.com/mail-back-envelopes-for-opioid-analgesics-dispensed-in-outpatient-settings-fda" title="" class="hs-featured-image-link"> <img src="https://blog.acutis.com/hubfs/BLOG-FDA-MAY25%20copy.jpg" alt="toxicology testing lab, fentanyl drug testing, drug testing lab ny " class="hs-featured-image"> </a> 
</div> 
<p><span>Opioid Use Disorder (OUD) </span></p> 
<p><span>is one of the biggest public health threats of this era with nearly 50,000 deaths (mostly preventable) from Opioid overdoses only in the US in 2019. Recently, there is an increasing trend of prescription opioid </span><span>use</span><span> for the treatment of chronic, non-cancer pain, such as back pain or osteoarthritis, despite serious risks and the lack of evidence for effectiveness. Unfortunately, there were nearly five times higher overdose deaths involving prescription opioids in 2020 than in 1999. In 2020 alone, almost 24% of all US opioid overdose deaths involved a prescription opioid. Since 1999, more than 263,000 people have died </span><span>in the US from</span><span> prescription opioid overdoses. These trends warranted immediate actions from government agencies.</span></p> 
<p> </p>  
<img src="https://track.hubspot.com/__ptq.gif?a=21140295&k=14&r=https%3A%2F%2Fblog.acutis.com%2Fmail-back-envelopes-for-opioid-analgesics-dispensed-in-outpatient-settings-fda&bu=https%253A%252F%252Fblog.acutis.com&bvt=rss" alt="" width="1" height="1">]]> </content:encoded>
</item>

<item>
<title>Opioids Recruit the Immune System to Cause Withdrawal Symptoms</title>
<link>https://edusehat.com/en/opioids-recruit-the-immune-system-to-cause-withdrawal-symptoms</link>
<guid>https://edusehat.com/en/opioids-recruit-the-immune-system-to-cause-withdrawal-symptoms</guid>
<description><![CDATA[  
    
 
Substance Use Disorder (SUD)   
is a growing public health problem with an estimated 165 million people among 12 and older in the US using some sort of substances. Substance use is associated with the development of significant physiological dependence, especially when consistently consumed in large amounts, and develop withdrawal symptoms when trying to stop using them. Withdrawal symptom is a physiological response to the sudden quitting or slowing of the substance use to which the body has grown dependent resulting in the unpleasant experience of combinations of physical, mental, and emotional symptoms. 
  ]]></description>
<enclosure url="https://blog.acutis.com/hubfs/blog-Opioids%20Recruit%20the%20Immune%20System%20to%20Cause%20Withdrawal%20Symptoms%202%20copy.jpg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 23 Feb 2026 12:40:42 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Opioids, Recruit, the, Immune, System, Cause, Withdrawal, Symptoms</media:keywords>
<content:encoded><![CDATA[<div class="hs-featured-image-wrapper"> 
 <a href="https://blog.acutis.com/opioids-recruit-the-immune-system-to-cause-withdrawal-symptoms" title="" class="hs-featured-image-link"> <img src="https://blog.acutis.com/hubfs/blog-Opioids%20Recruit%20the%20Immune%20System%20to%20Cause%20Withdrawal%20Symptoms%202%20copy.jpg" alt="toxicology testing lab, fentanyl drug testing, drug testing lab new york" class="hs-featured-image"> </a> 
</div> 
<p><span><span>Substance Use Disorder (SUD) </span> </span></p> 
<p><span>is a growing public health problem with an estimated 165 million people among 12 and older in the US using some sort of substances. Substance use is associated with the development of significant physiological dependence, especially when consistently consumed in large amounts, and develop withdrawal symptoms when trying to stop using them. Withdrawal symptom is a physiological response to the sudden quitting or slowing of the substance use to which the body has grown dependent resulting in the unpleasant experience of combinations of physical, mental, and emotional symptoms.</span></p> 
<p> </p>  
<img src="https://track.hubspot.com/__ptq.gif?a=21140295&k=14&r=https%3A%2F%2Fblog.acutis.com%2Fopioids-recruit-the-immune-system-to-cause-withdrawal-symptoms&bu=https%253A%252F%252Fblog.acutis.com&bvt=rss" alt="" width="1" height="1">]]> </content:encoded>
</item>

<item>
<title>Mix&#45;and&#45;match COVID 19 vaccine regimen</title>
<link>https://edusehat.com/en/mix-and-match-covid-19-vaccine-regimen</link>
<guid>https://edusehat.com/en/mix-and-match-covid-19-vaccine-regimen</guid>
<description><![CDATA[  
    
 
 
  
   
    
     
      
       
        
       
      
     
    Before the emergence of the Omicron variant, evidence showed the enhanced effectiveness of combining two different COVID-19 vaccines in preventing the disease and protecting us against the Delta variant with the potential to influence the system going forward. 
    The natural experiment of mix-and-matching COVID-19 vaccines began last March because of the extremely rare but serious side effects that occurred from the AstraZeneca vaccine. The negative outcomes resulted in halting the distribution of the AstraZeneca and using a different vaccine as the second dose. Three studies have independently confirmed the increased effectiveness of mix-and-match regimens for various populations at various times — including during the rise of the hyper-infectious Delta variant — and enhanced immune response among immunosuppressed individuals. 
    Although the effectiveness of the mix-and-match COVID-19 vaccines regimen is now well-established, how well this vaccine regimen will hold up over time and whether and when boosters are needed is still to be determined. Further research is required to determine whether the mix-and-match vaccine regimen will be an effective defense against the heavily-mutated Omicron variant. 
    Read more here.  
      
     
      
       
       
         GET IN TOUCH 
         
      
     
    
   
  
 ]]></description>
<enclosure url="https://blog.acutis.com/hubfs/Imported_Blog_Media/6f340a_701c6f4fb7ff4922a5ac52cd7a59e81e~mv2.jpeg" length="49398" type="image/jpeg"/>
<pubDate>Mon, 23 Feb 2026 12:40:41 +0700</pubDate>
<dc:creator>Edusehat</dc:creator>
<media:keywords>Mix-and-match, COVID, vaccine, regimen</media:keywords>
<content:encoded><![CDATA[<div class="hs-featured-image-wrapper"> 
 <a href="https://blog.acutis.com/post/mix-and-match-covid-19-vaccine-regimen" title="" class="hs-featured-image-link"> <img src="https://blog.acutis.com/hubfs/Imported_Blog_Media/6f340a_701c6f4fb7ff4922a5ac52cd7a59e81e~mv2.jpeg" alt="covid 19 pcr testing lab, infectious disease testing lab" class="hs-featured-image"> </a> 
</div> 
<div class="NjQ71C"> 
 <div class="NjQ71C"> 
  <div class="kvdbP HWlYoF wrLZsV _1O7aH"> 
   <div class="_1hN1O uyQefQ"> 
    <div class="_2vd5k b6lcWf"> 
     <div class="_3CWa- sxFoib sxFoib _3mymk"> 
      <div class="_2kEVY"> 
       <div class="_3WJnn _2i-Gt"></div> 
      </div> 
     </div> 
    </div> 
    <p class="mm8Nw _1j-51 roLFQS _1FoOD _78FBa sk96G9 roLFQS public-DraftStyleDefault-block-depth0 public-DraftStyleDefault-text-ltr"><span class="_2PHJq public-DraftStyleDefault-ltr"><span>Before the emergence of the <a href="https://www.acutis.com/post/omicron-the-heavily-mutated-covid-19-variant" class="_3Bkfb _1lsz7">Omicron variant</a>, evidence showed the enhanced effectiveness of combining two different COVID-19 vaccines in preventing the disease and protecting us against the <a href="https://www.linkedin.com/feed/update/urn:li:activity:6829129373833080832" class="_3Bkfb _1lsz7">Delta variant</a> with the potential to influence the system going forward.</span></span></p> 
    <p class="mm8Nw _1j-51 roLFQS _1FoOD _78FBa sk96G9 roLFQS public-DraftStyleDefault-block-depth0 public-DraftStyleDefault-text-ltr"><span class="_2PHJq public-DraftStyleDefault-ltr"><span>The natural experiment of mix-and-matching COVID-19 vaccines began last March because of the extremely rare but serious <a href="https://www.webmd.com/drugs/2/drug-180610/astrazeneca-covid-19-vaccine-pfunapproved-intramuscular/details/list-sideeffects" class="_3Bkfb _1lsz7">side effects that occurred from the AstraZeneca vaccine</a>. The negative outcomes resulted in halting the distribution of the AstraZeneca and using a different vaccine as the second dose. Three studies have independently confirmed the increased effectiveness of mix-and-match regimens for various populations at various times — including during the rise of the hyper-infectious Delta variant — and enhanced immune response among immunosuppressed individuals.</span></span></p> 
    <p class="mm8Nw _1j-51 roLFQS _1FoOD _78FBa sk96G9 roLFQS public-DraftStyleDefault-block-depth0 public-DraftStyleDefault-text-ltr"><span class="_2PHJq public-DraftStyleDefault-ltr"><span>Although the effectiveness of the mix-and-match COVID-19 vaccines regimen is now well-established, how well this vaccine regimen will hold up over time and whether and when boosters are needed is still to be determined. Further research is required to determine whether the mix-and-match vaccine regimen will be an effective defense against the heavily-mutated Omicron variant.</span></span></p> 
    <p class="mm8Nw _1j-51 roLFQS _1FoOD _78FBa sk96G9 roLFQS public-DraftStyleDefault-block-depth0 public-DraftStyleDefault-text-ltr"><span class="_2PHJq public-DraftStyleDefault-ltr"><span><strong><span>Read more </span></strong><a href="https://www.nature.com/articles/d41586-021-02853-4" class="_3Bkfb _1lsz7"><strong><span>here</span></strong></a><strong><span>. </span></strong></span></span></p> 
    <p> </p> 
    <div class="_2vd5k b6lcWf"> 
     <div class="_3ZwKi _3CWa- sxFoib sxFoib _1eLXB"> 
      <a class="iRkxq" href="https://www.acutis.com/contact"> 
       <div class="_3Ybc9">
         GET IN TOUCH 
       </div> </a> 
     </div> 
    </div> 
   </div> 
  </div> 
 </div> 
</div>  
<img src="https://track.hubspot.com/__ptq.gif?a=21140295&k=14&r=https%3A%2F%2Fblog.acutis.com%2Fpost%2Fmix-and-match-covid-19-vaccine-regimen&bu=https%253A%252F%252Fblog.acutis.com&bvt=rss" alt="" width="1" height="1">]]> </content:encoded>
</item>

</channel>
</rss>